Keyword

CANVAS Program

Description: A clinical trial program evaluating the cardiovascular and renal effects of canagliflozin in people with type 2 diabetes and elevated cardiovascular risk.
OpenAlex ID: keywords/canvas-program
2019 · JingWei Li, Mark Woodward, et al. · JACC Heart Failure · 148
2019 · David R. Matthews, Qiang Li, et al. · Diabetologia · 143
2020 · Yasuhiro Maejima · Frontiers in Cardiovascular Medicine · 142
2019 · Karin Rådholm, Zien Zhou, et al. · Diabetes Obesity and Metabolism · 87
2018 · Aaron Y. Kluger, Kristen M. Tecson, et al. · Reviews in Cardiovascular Medicine · 85
2017 · Emma D. Deeks, André J. Scheen · Drugs · 66
2019 · JingWei Li, Sunil V Badve, et al. · The Lancet Rheumatology · 63
2021 · Ricardo Fontes-Carvalho, Diogo Santos-Ferreira, et al. · European Journal of Preventive Cardiology · 50
2020 · Clare Arnott, Yuli Huang, et al. · Diabetes Obesity and Metabolism · 47
2020 · Vikas S. Sridhar, Habib U. Rahman, et al. · Diabetes Obesity and Metabolism · 28
2018 · Tricia Santos Cavaiola, Jeremy Pettus · Diabetes Metabolic Syndrome and Obesity · 27
2017 · Michael d'Emden, John Amerena, et al. · Diabetes Research and Clinical Practice · 27
2024 · Angelica Cersosimo, Andrea Drera, et al. · Kidney and Dialysis · 24
2018 · Nobuya Inagaki, Shin-ichi Harashima, et al. · Expert Opinion on Pharmacotherapy · 18
Works count: 224
Citation count: 1,785
Year
Topic
Type